Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Buprenorphine and Naloxone in Hepatic Impairment and HCV
NCT01846455Phase 4Completed
- Sponsor
- Indivior
- Start
- Sep 2012
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Suboxone in opioid use disorder (OUD) (5 arms), sponsored by Indivior. Primary endpoints: Area Under the Concentration-time Curve From Time Zero to Time of Last Measurable Concentration, Maximum Observed Plasma Concentration and 8 more. Started Sep 2012; status: completed.
02
Drugs
Suboxone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT01846455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01846455.